Overexpression of membrane sialic acid-specific sialidase Neu3 inhibits matrix metalloproteinase-9 expression in vascular smooth muscle cells

Biochemical and Biophysical Research Communications

Volumn 356, Issue 3, 2007, Pages 542-547

  Moon, Sung Kwon ^a   Cho, Seung Hak ^a   Kim, Kyung Woon ^a   Jeon, Jae Heung ^b   Ko, Jeong Heon ^b   Kim, Bo Yeon ^b   Kim, Cheorl Ho ^a  

^a Sungkyunkwan University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

AP 1; Atherosclerosis; MMP 9; NF B; Sialidase Neu3 gene; Vascular smooth muscle cell

Indexed keywords

GELATINASE B; SIALIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; GENE; GENE OVEREXPRESSION; MOUSE; NEU3 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL PROLIFERATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MUSCLE, SMOOTH, VASCULAR; NEURAMINIDASE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33947654342     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.02.155     Document Type: Article

References (33)

1. Pilatte Y., Bignon J., and Lambré C.R. Sialic acids as important molecules in the regulation of the immune system: pathophysiological implications of sialidases in immunity. Glycobiology 3 (1993) 201-217
2. Miyagi T., Wada T., Yamaguchi K., and Hata K. Sialidase and malignancy: a minireview. Glycoconj. J. 20 3 (2004) 189-198
3. Miyagi T., and Tsuiki S. Rat-liver lysosomal sialidase. Solubilization, substrate specificity and comparison with the cytosolic sialidase. Eur. J. Biochem. 141 (1984) 75-81
4. Miyagi T., and Tsuiki S. Purification and characterization of cytosolic sialidase from rat liver. J. Biol. Chem. 260 (1985) 6710-6716
5. Miyagi T., Sagawa J., Konno K., Handa S., and Tsuiki S. Biochemical and immunological studies on two distinct ganglioside-hydrolyzing sialidases from the particulate fraction of rat brain. J. Biochem. 107 (1990) 787-793
6. Miyagi T., Konno K., Emori Y., Kawasaki H., Suzuki K., Yasui A., and Tsuiki S. Molecular cloning and expression of cDNA encoding rat skeletal muscle cytosolic sialidase. J. Biol. Chem. 268 (1993) 26435-26440
7. van der Spoel A., Bonten E., and d'Azoo A. Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A. EMBO J. 17 (1998) 1588-1597
8. Kopitz J., von Reitzenstein C., Sinz K., and Cantz M. Selective ganglioside desialylation in the plasma membrane of human neuroblastoma cells. Glycobiology 6 (1996) 367-376
9. Kopitz J., Sinz K., Brossmer R., and Cantz M. Partial characterization and enrichment of a membrane-bound sialidase specific for gangliosides from human brain tissue. Eur. J. Biochem. 248 (1997) 527-534
10. Hata K., Wada T., Hasegawa A., Kiso M., and Miyagi T. Purification and characterization of a membrane-associated ganglioside sialidase from bovine brain. J. Biochem. (Tokyo) 123 (1998) 899-905
11. Miyagi T., Wada T., Iwamatsu A., Hata K., Yoshikawa Y., Tokuyama S., and Sawada M. Molecular cloning and characterization of a plasma membrane-associated sialidase specific for gangliosides. J. Biol. Chem. 274 (1999) 5004-5011
12. Wada T., Yoshikawa Y., Tokuyama S., Kuwahara M., Akita H., and Miyagi T. Cloning, expression, and chromosomal mapping of a human ganglioside sialidase. Biochem. Biophys. Res. Commun. 261 (1999) 1-27
13. Monti E., Bassi M.T., Papini N., Riboni M., Manzoni M., Venerando B., Croci G., Preti A., Ballabio A., and Tettamanti G. Identification and expression of NEU3, a novel human sialidase associated to the plasma membrane. Biochem. J. 349 (2000) 343-351
14. Hakomori S., Yamamura S., and Handa K. Signal transduction through glyco(sphingo)lipids: introduction and recent studies on glyco(sphingo)lipid-enriched microdomains. Ann. N. Y. Acad. Sci. 845 (1998) 1-10
15. Usuki S., Lyu S.C., and Sweeley C.C. Sialidase activities of cultured human fibroblasts and the metabolism of GM3 ganglioside. J. Biol. Chem. 263 (1988) 6847-6853
16. Yogeeswaran G., and Hakomori S. Cell contact-dependent ganglioside changes in mouse 3T3 gibroblasts and a suppressed sialidase activity on cell contact. Biochemistry 14 (1975) 2151-2156
17. Wang Y., Yamaguchi K., Wada T., Hata K., Zhao X., Fujimoto T., and Miyagi T. A close association of the ganglioside-specific sialidase Neu3 with caveolin membrane microdomains. J. Biol. Chem. 277 29 (2002) 26252-26259
18. Kakugawa Y., Wada T., Yamaguchi K., Yamanami H., Ouchi K., Sato I., and Miyagi T. Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc. Natl. Acad. Sci. USA 99 16 (2002) 10718-10723
19. Sasaki A., Hata K., Suzuki S., Sawada M., Wada T., Yamaguchi K., Obinata M., Tateno H., Suzuki H., and Miyagi T. Overexpression of plasma membrane-associated sialidase attenuates insulin signaling in transgenic mice. J. Biol. Chem. 278 30 (2003) 27896-27902
20. Cuniberti L.A., Martinez V., Schachter J., Magarinos G., Meckert P.C., Laguens R.P., Levenson J., and Werba J.P. Sialic acid as a protective barrier against neointima development. Atherosclerosis 181 2 (2005) 225-231
21. Tertov V.V., Kaplun V.V., Sobenin I.A., Boytsova E.Y., Bovin N.V., and Orekhov A.N. Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein. Atherosclerosis 159 1 (2001) 103-115
22. Tertov V.V., Kaplun V.V., Sobenin I.A., and Orekhov A.N. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification. Atherosclerosis 138 1 (1998) 183-195
23. Golovanova N.K., Gracheva E.V., Il'inskaya O.P., Tararak E.M., and Prokazova N.V. Sialidase activity in normal and atherosclerotic human aortic intima. Biochemistry (Mosc) 67 11 (2002) 1230-1234
24. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
25. Abedi H., and Zachary I. Signalling mechanisms in the regulation of vascular cell migration. Cardiovasc. Res. 30 (1995) 544-556
26. Clausell N., Lima V.C., and Molossi S. Expression of tumor necrosis factor alpha and accumulation of fibronectin in coronary artery restenotic lesions retrieved by atherectomy. Br. Heart J. 73 (1995) 534-539
27. Moon S.K., Cha B.Y., and Kim C.H. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway. J. Cell. Physiol. 198 (2004) 417-427
28. Moon S.K., Cho G.O., Jung S.Y., Gal S.W., Kwon T.K., Lee Y.C., Madamanchi N.R., and Kim C.H. Quercetin exerts multiple inhibitory effects on vascular smooth muscle cells: role of ERK1/2, cell-cycle regulation, and matrix metalloproteinase-9. Biochem. Biophys. Res. Commun. 301 (2003) 1069-1078
29. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
30. Newby A.C., and Zaltsman A.B. Molecular mechanisms in intimal hyperplasia. J. Pathol. 190 (2000) 300-309
31. Cho A., and Reidy M.A. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ. Res. 91 (2002) 845-851
32. Sato H., Kita M., and Seiki M. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J. Biol. Chem. 268 (1993) 23460-23468
33. Kato K., Shiga K., Yamaguchi K., Hata K., Kobayashi T., Miyazaki K., Saijo S., and Miyagi T. Plasma membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibronectin-derived signaling. Biochem. J. 394 (2006) 647-656